Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

More articles from Article

  • You have access
    Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma
    IOANNIS PANAGOPOULOS, LUDMILA GORUNOVA, KRISTIN ANDERSEN, MARIUS LUND-IVERSEN, SVETLANA TAFJORD, FRANCESCA MICCI and SVERRE HEIM
    Cancer Genomics & Proteomics November 2021, 18 (6) 723-734; DOI: https://doi.org/10.21873/cgp.20293
  • You have access
    Colon Cancer Progression Is Reflected to Monotonic Differentiation in Gene Expression and Pathway Deregulation Facilitating Stage–specific Drug Repurposing
    MARILENA M. BOURDAKOU, GEORGE M. SPYROU and GEORGE KOLIOS
    Cancer Genomics & Proteomics November 2021, 18 (6) 757-769; DOI: https://doi.org/10.21873/cgp.20295
  • You have access
    OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation
    RICUPHAN KHAMKO, JUREERUT DADUANG, CHATRI SETTASATIAN and TEMDUANG LIMPAIBOON
    Cancer Genomics & Proteomics November 2021, 18 (6) 771-780; DOI: https://doi.org/10.21873/cgp.20296
  • You have access
    CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
    GWAN HEE HAN, JULIE KIM, HEE YUN, HANBYOUL CHO, JOON-YONG CHUNG, JAE-HOON KIM and STEPHEN M. HEWITT
    Cancer Genomics & Proteomics November 2021, 18 (6) 699-713; DOI: https://doi.org/10.21873/cgp.20291
  • You have access
    Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis
    FEDERICA CIREGIA, FILOMENA CETANI, ELENA PARDI, ALESSIO SOGGIU, CRISTIAN PIRAS, LORENZO ZALLOCCO, SIMONA BORSARI, MAURIZIO RONCI, VANNI CARUSO, CLAUDIO MARCOCCI, MARIA ROSA MAZZONI, ANTONIO LUCACCHINI and LAURA GIUSTI
    Cancer Genomics & Proteomics November 2021, 18 (6) 781-796; DOI: https://doi.org/10.21873/cgp.20297
  • You have access
    Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models
    YUSUKE AOKI, JUN YAMAMOTO, YASUNORI TOME, KAZUYUKI HAMADA, NORIYUKI MASAKI, SACHIKO INUBUSHI, YOSHIHIKO TASHIRO, MICHAEL BOUVET, ITARU ENDO, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics November 2021, 18 (6) 715-721; DOI: https://doi.org/10.21873/cgp.20292
  • You have access
    Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
    MD MOHIUDDIN and KAZUO KASAHARA
    Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
  • You have access
    Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
    SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM
    Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290
  • You have access
    SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
    JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
    Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289
  • You have access
    Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
    ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
    Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire